Poly (ADP-Ribose) Polymerase inhibitors (PARPi) therapy response in an acral melanoma patient with EMSY gene amplification

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)59-61
Number of pages3
JournalJAAD Case Reports
Volume48
DOIs
StatePublished - Jun 2024

Keywords

  • EMSY
  • PARPi
  • acral melanoma
  • immunotherapy resistance

Cite this